Acuta Capital Partners’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
GGHC
NAMA
AIM
Acuta Capital Partners's VCYT Position: Q4 2019 in Review
Acuta Capital Partners sold out of Veracyte (VCYT) in Q4 2019, closing a stake of 112,500 shares — an estimated $2.7M sold.
Acuta Capital Partners first reported a position in VCYT in Q4 2014 and held it in 19 quarters. The position peaked at $28.9M in Q3 2017. 179 funds tracked by Wall St. Rank hold VCYT as of Q4 2019.
- Acuta Capital Partners reported no remaining Veracyte position as of Q4 2019 after selling out during the quarter.
- Acuta Capital Partners sold 112,500 Veracyte shares in Q4 2019, an estimated $2.7M.
- Acuta Capital Partners first reported a position in Veracyte in Q4 2014 and held it in 19 quarters.
- Acuta Capital Partners's Veracyte position peaked at $28.9M in Q3 2017.
- 179 funds tracked by Wall St. Rank held Veracyte as of Q4 2019.
Based on Acuta Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.